Jeffrey Kroon has been award a Vidi grant by the Dutch Research Council (NWO) for his research on the role of the endothelium during atherogenesis. The grant enables experienced researchers to develop their own innovative line of research and set up or expand their own research group in the next five years.
A novel role for the endothelium as active immunomodulator during atherogenesis
With this project Jeffrey Kroon explores the critical role of inflammation in cardiovascular disease (CVD) and aims to modulate the immune system by targeting how endothelial cells—the cells lining our blood vessels—function. Acting as 'gatekeepers,' these cells can either promote or reduce inflammation, offering a unique opportunity to fine-tune the body's immune response. The ultimate goal is to harness the immunomodulatory properties of the endothelium to reduce inflammation and develop more effective strategies to combat CVD.
Dr. Jeffrey Kroon
About the Vidi grant
Vidi is a funding instrument in the NWO Talent Programme. It allows researchers who have already spent several years doing postdoctoral research to develop or expand their own innovative line of research. This year, NWO has awarded a Vidi grant to 102 researchers, of which three went to Amsterdam UMC researchers. Read more about the 2023 laureates and there projects.